Life Sciences Spotlight – Volume 3 – Turning Insight Into Action: A Life Sciences Playbook for 2026

Start
Clients & Friends, Looking back on 2025, one word comes to mind: resiliency. The life sciences sector has taken some hits, but it kept moving. Public markets are showing real signs of life again. The private side – frozen at times – is beginning to thaw. Investors are stepping back in, deals are returning and companies that spent two years tightening their belts are coming to market with a clearer sense of purpose. It’s a welcome shift that appears to be rewarding those who remained patient….
By: Polsinelli
Previous Story

2026 NDAA Updates to Outbound Investment Rule

Next Story

Protecting AI-Assisted Innovation: Navigating USPTO Guidance and Compliance